Adenosine 5′-monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes

Biology of Reproduction

Volumn 76, Issue 4, 2007, Pages 589-597

  Mayes, Mario A ^a   Laforest, Martin F ^a   Guillemette, Christine ^a   Gilchrist, Robert B ^b   Richard, François J ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Follicle; Gamete biology; Meiosis; Ovum

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE PHOSPHATE; ADENYLATE KINASE; CILOSTAMIDE; METFORMIN; PHOSPHODIESTERASE III INHIBITOR; PROTEIN PRKA; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; ISOENZYME; PHOSPHODIESTERASE INHIBITOR; RIBONUCLEOTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUMULUS OOPHORUS; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SUBUNIT; FEMALE; GENE; GRANULOSA CELL; IMMUNOBLOTTING; MEIOSIS; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE MATURATION; PRIORITY JOURNAL; PRKAA1 GENE; PRKAB1 GENE; PRKAG1 GENE; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TRANSCRIPTOMICS; ZONA PELLUCIDA; ANIMAL; DRUG EFFECT; METABOLISM; OOCYTE; ORGAN CULTURE TECHNIQUE; OVARY FOLLICLE; PHYSIOLOGY;

SUS;

AMINOIMIDAZOLE CARBOXAMIDE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; ISOENZYMES; MEIOSIS; OOCYTES; ORGAN CULTURE TECHNIQUES; OVARIAN FOLLICLE; PHOSPHODIESTERASE INHIBITORS; RIBONUCLEOTIDES; SUS SCROFA;

EID: 33947519633     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.057828     Document Type: Article

References (91)

1. Tsafriri A, Dekel N. Molecular Mechanisms in Ovulation. San Diego: Academic Press; 1994.
2. Edwards RG. Maturation in vitro of mouse, sheep, cow, pig, rhesus monkey and human ovarian oocytes. Nature 1965; 208:349-351.
3. Hyttel P, Callesen H, Greve T. Ultrastructural features of preovulatory oocyte maturation in superovulated cattle. J Reprod Fertil 1986; 76:645-656.
4. Pincus G, Enzmann EV. The comparative behavior of mammalian eggs in vivo and in vitro: I. The activation of ovarian eggs. J Exp Med 1935; 62: 665-675.
5. Cho WK, Stern S, Biggers JD. Inhibitory effect of dibutyryl cAMP on mouse oocyte maturation in vitro. J Exp Zool 1974; 187:383-386.
6. Aberdam E, Hanski E, Dekel N. Maintenance of meiotic arrest in isolated rat oocytes by the invasive adenylate cyclase of Bordetella pertussis. Biol Reprod 1987; 36:530-535.
7. Aktas H, Wheeler MB, Rosenkrans CF Jr, First NL, Leibfried-Rutledge ML. Maintenance of bovine oocytes in prophase of meiosis I by high [cAMP]i. J Reprod Fertil 1995; 105:227-235.
8. Conti M, Andersen CB, Richard F, Mehats C, Chun SY, Horner K, Jin C, Tsafriri A. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol 2002; 187:153-159.
9. Salustri A, Petrungajo S, De Felici M, Conti M, Siracusa G. Effect of follicle-stimulating hormone on cyclic adenosine monophosphate level and on meiotic maturation in mouse cumulus cell-enclosed oocytes cultured in vitro. Biol Reprod 1985; 33:797-802.
10. Dekel N, Aberdam E, Sherizly I. Spontaneous maturation in vitro of cumulus-enclosed rat oocytes is inhibited by forskolin. Biol Reprod 1984; 31:244-250.
11. Sirard MA, First NL. In vitro inhibition of oocyte nuclear maturation in the bovine. Biol Reprod 1988; 39:229-234.
12. Vivarelli E, Conti M, De Felici M, Siracusa G. Meiotic resumption and intracellular cAMP levels in mouse oocytes treated with compounds which act on cAMP metabolism. Cell Differ 1983; 12:271-276.
13. Bilodeau-Goeseels S. Effects of phosphodiesterase inhibitors on spontaneous nuclear maturation and cAMP concentrations in bovine oocytes. Theriogenology 2003; 60:1679-1690.
14. Jensen JT, Schwinof KM, Zelinski-Wooten MB, Conti M, DePaolo LV, Stouffer RL. Phosphodiesterase 3 inhibitors selectively block the spontaneous resumption of meiosis by macaque oocytes in vitro. Hum Reprod 2002; 17:2079-2084.
15. Laforest MF, Pouliot E, Gueguen L, Richard FJ. Fundamental significance of specific phosphodiesterases in the control of spontaneous meiotic resumption in porcine oocytes. Mol Reprod Dev 2005; 70:361-372.
16. Mayes MA, Sirard MA. Effect of type 3 and type 4 phosphodiesterase inhibitors on the maintenance of bovine oocytes in meiotic arrest. Biol Reprod 2002; 66:180-184.
17. Nogueira D, Albano C, Adriaenssens T, Cortvrindt R, Bourgain C, Devroey P, Smitz J. Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod 2003; 69:1042-1052.
18. Shitsukawa K, Andersen CB, Richard FJ, Horner AK, Wiersma A, van Duin M, Conti M. Cloning and characterization of the cyclic guanosine monophosphate-inhibited phosphodiesterase PDE3A expressed in mouse oocyte. Biol Reprod 2001; 65:188-196.
19. Thomas RE, Armstrong DT, Gilchrist RB. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation. Dev Biol 2002; 244:215-225.
20. Tsafriri A, Chun SY, Zhang R, Hsueh AJ, Conti M. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol 1996; 178:393-402.
21. Downs SM, Hunzicker-Dunn M. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate. Dev Biol 1995; 172:72-85.
22. Homa ST. Effects of cyclic AMP on the spontaneous meiotic maturation of cumulus-free bovine oocytes cultured in chemically defined medium. J Exp Zool 1988; 248:222-231.
23. Magnusson C, Hillensjo T. Inhibition of maturation and metabolism in rat oocytes by cyclic amp. J Exp Zool 1977; 201:139-147.
24. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 1997; 246:259-273.
25. Stapleton D, Woollatt E, Mitchelhill KI, Nicholl JK, Fernandez CS, Michell BJ, Witters LA, Power DA, Sutherland GR, Kemp BE. AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett 1997; 409:452-456.
26. Stapleton D, Gao G, Michell BJ, Widmer J, Mitchelhill K, Teh T, House CM, Witters LA, Kemp BE. Mammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinase. J Biol Chem 1994; 269:29343-29346.
27. Cheung PC, Salt JP, Davies SP, Hardie DG, Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J 2000; 346:659-669.
28. Thornton C, Snowden MA, Carling D. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J Biol Chem 1998; 273:12443-12450.
29. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998; 67:821-855.
30. Hardie DG. Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 2003; 144:5179-5183.
31. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47:1369-1373.
32. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, Vaulont S, Richter EA, Wojtaszewski JF. Knockout of the alpha2 but not alphal 5′-AMP-activated protein kinase isoform abolishes 5-amino-imidazole-4- carboxamide-1-beta-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 2004; 279: 1070-1079.
33. Carling D, Hardie DG. The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase. Biochim Biophys Acta 1989; 1012:81-86.
34. Foretz M, Carling D, Guichard C, Ferre P, Foufelle F. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes. J Biol Chem 1998; 273:14767-14771.
35. Velasco G, Geelen MJ, Guzman M. Control of hepatic fatty acid oxidation by 5′-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 1997; 337:169-175.
36. Hardie DG, Salt IP, Hawley SA, Davies SP. AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 1999; 338:717-722.
37. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci 2004; 117:5479-5487.
38. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005; 280:29060-29066.
39. Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1:15-25.
40. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995; 229:558-565.
41. Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002; 277:25226-25232.
42. Hawley SA, Gadalla AE, Olsen GS, Hardie DG. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 2002; 51:2420-2425.
43. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108:1167-1174.
44. Goodarzi MO, Bryer-Ash M. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents. Diabetes Obes Metab 2005; 7:654-665.
45. Ben-Haroush A, Yogev Y, Fisch B. Insulin resistance and metformin in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004; 115:125-133.
46. Chen J, Hudson E, Chi MM, Chang AS, Moley KH, Hardie DG, Downs SM. PRKA regulation of mouse oocyte meiotic resumption in vitro. Dev Biol 2006; 291:227-238.
47. Downs SM, Hudson ER, Hardie DG. A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes. Dev Biol 2002; 245: 200-212.
48. Petters RM, Wells KD. Culture of pig embryos. J Reprod Fertil Suppl 1993; 48:61-73.
49. Bureau M, Bailey JL, Sirard MA. Influence of oviductal cells and conditioned medium on porcine gametes. Zygote 2000; 8:139-144.
50. Funahashi H, Cantley TC, Day BN. Synchronization of meiosis in porcine oocytes by exposure to dibutyryl cyclic adenosine monophosphate improves developmental competence following in vitro fertilization. Biol Reprod 1997; 57:49-53.
51. Motlik J, Koefoed-Johnsen HH, Fulka J. Breakdown of the germinal vesicle in bovine oocytes cultivated in vitro. J Exp Zool 1978; 205:377-383.
52. Prochazka R, Nemcova L, Nagyova E, Kanka J. Expression of growth differentiation factor 9 messenger RNA in porcine growing and preovulatory ovarian follicles. Biol Reprod 2004; 71:1290-1295.
53. Niesler CU, Myburgh KH, Moore F. The changing PRKA expression profile in differentiating skeletal muscle myoblast cells helps confer increasing resistance to apoptosis. Exp Physiol 2006; (in press).
54. Rubin LJ, Magliola L, Feng X, Jones AW, Hale CC. Metabolic activation of AMP kinase in vascular smooth muscle. J Appl Physiol 2005; 98:296-306.
55. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 2003; 278:39422-39427.
56. Suryawan A, Nguyen HV, Bush JA, Davis TA. Developmental changes in the feeding-induced activation of the insulin-signaling pathway in neonatal pigs. Am J Physiol Endocrinol Metab 2001; 281:E908-915.
57. Downs SM, Eppig JJ. Cyclic adenosine monophosphate and ovarian follicular fluid act synergistically to inhibit mouse oocyte maturation. Endocrinology 1984; 114:418-427.
58. Downs SM, Coleman DL, Ward-Bailey PF, Eppig JJ. Hypoxanthine is the principal inhibitor of murine oocyte maturation in a low molecular weight fraction of porcine follicular fluid. Proc Natl Acad Sci U S A 1985; 82: 454-458.
59. Bornslaeger EA, Wilde MW, Schultz RM. Regulation of mouse oocyte maturation: involvement of cyclic AMP phosphodiesterase and calmodulin. Dev Biol 1984; 105:488-499.
60. Bornslaeger EA, Mattei PM, Schultz RM. Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Development Biology 1986; 114:453-462.
61. Pilon G, Dallaire P, Marette A. Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem 2004; 279:20767-20774.
62. Saha AK, Schwarsin AJ, Roduit R, Masse F, Kaushik V, Tornheim K, Prentki M, Ruderman NB. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside. J Biol Chem 2000; 275:24279-24283.
63. Nagata D, Mogi M, Walsh K. AMP-activated protein kinase (PRKA) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003; 278:31000-31006.
64. Shang J, Lehrman MA. Activation of glycogen phosphorylase with 5-aminoimidazole-4-carboxarnide riboside (AICAR). Assessment of glycogen as a precursor of mannosyl residues in glycoconjugates. J Biol Chem 2004; 279:12076-12080.
65. Chesnel F, Eppig JJ. Synthesis and accumulation of p34cdc2 and cyclin B in mouse oocytes during acquisition of competence to resume meiosis. Mol Reprod Dev 1995; 40:503-508.
66. Fulka J Jr, Motlik J, Fulka J, Jilek F. Effect of cycloheximide on nuclear maturation of pig and mouse oocytes. J Reprod Fertil 1986; 77:281-285.
67. Kuroda T, Naito K, Sugiura K, Yamashita M, Takakura I, Tojo H. Analysis of the roles of cyclin B1 and cyclin B2 in porcine oocyte maturation by inhibiting synthesis with antisense RNA injection. Biol Reprod 2004; 70:154-159.
68. Kubelka M, Motik J, Fulka J Jr, Prochazka R, Rimkevicova Z, Fulka J. Time sequence of germinal vesicle breakdown in pig oocytes after cycloheximide and P-aminobenzamidine block. Gamete Res 1988; 19: 423-431.
69. Hunter AG, Moor RM. Stage-dependent effects of inhibiting ribonucleic acids and protein synthesis on meiotic maturation of bovine oocytes in vitro. J Dairy Sci 1987; 70:1646-1651.
70. Byskov AG, Andersen CY, Hossaini A, Guoliang X. Cumulus cells of oocyte-cumulus complexes secrete a meiosis-activating substance when stimulated with FSH. Mol Reprod Dev 1997; 46:296-305.
71. Byskov AG, Andersen CY, Nordholm L, Thogersen H, Guoliang X, Wassmann O, Andersen JV, Guddal E, Roed T. Chemical structure of sterols that activate oocyte meiosis. Nature 1995; 374:559-562.
72. Shimada M, Terada T. FSH and LH induce progesterone production and progesterone receptor synthesis in cumulus cells: a requirement for meiotic resumption in porcine oocytes. Mol Hum Reprod 2002; 8:612-618.
73. Yamashita Y, Nishibori M, Terada T, Isobe N, Shimada M. Gonadotropin-induced delta14-reductase and delta7-reductase gene expression in cumulus cells during meiotic resumption of porcine oocytes. Endocrinology 2005; 146:186-194.
74. Meinecke B, Meinecke-Tillmann S. Effects of alpha-amanitin on nuclear maturation of porcine oocytes in vitro. J Reprod Fertil 1993; 98:195-201.
75. Marie S, Heron B, Bitoun P, Timmerman T, Van Den Berghe G, Vincent MF. AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC. Am J Hum Genet 2004; 74:1276-1281.
76. Wall M, Shim JH, Benkovic SJ. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis. Biochemistry 2000; 39:11303-11311.
77. Zimmermann AG, Gu JJ, Laliberte J, Mitchell BS. Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation. Prog Nucleic Acid Res Mol Biol 1998; 61:181-209.
78. Barsotti C, Pesi R, Felice F, Ipata PL. The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles. Cell Mol Life Sci 2003; 60: 786-793.
79. Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 2003; 31:224-227.
80. Salaun P, Le Breton M, Morales J, Belle R, Boulben S, Mulner-Lorillon O, Cormier P. Signal transduction pathways that contribute to CDK1/ cyclin B activation during the first mitotic division in sea urchin embryos. Exp Cell Res 2004; 296:347-357.
81. Gavin AC, Schorderet-Slatkine S. Ribosomal S6 kinase p90rsk and mRNA cap-binding protein eIF4E phosphorylations correlate with MAP kinase activation during meiotic reinitiation of mouse oocytes. Mol Reprod Dev 1997; 46:383-391.
82. Horman S, Browne G, Krause U, Patel J, Vertommen D, Bertrand L, Lavoinne A, Hue L, Proud C, Rider M. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 2002; 12:1419-1423.
83. Le Beux G, Richard FJ, Sirard MA. Effect of cycloheximide, 6-DMAP, roscovitine and butyrolactone I on resumption of meiosis in porcine oocytes. Theriogenology 2003; 60:1049-1058.
84. Thompson JG, Lane M, Gilchrist RB. Metabolism of the bovine cumulus oocyte complex and influence on subsequent developmental competence. Reproduction 2006; (in press).
85. Rieger D, Loskutoff NM. Changes in the metabolism of glucose, pyruvate, glutamine and glycine during maturation of cattle oocytes in vitro. J Reprod Fertil 1994; 100:257-262.
86. Zuelke KA, Brackett BG. Effects of luteinizing hormone on glucose metabolism in cumulus-enclosed bovine oocytes matured in vitro. Endocrinology 1992; 131:2690-2696.
87. Sutton-McDowall ML, Gilchrist RB, Thompson JG. Cumulus expansion and glucose utilisation by bovine cumulus-oocyte complexes during in vitro maturation: the influence of glucosamine and follicle-stimulating hormone. Reproduction 2004; 128:313-319.
88. Iwata H, Hashimoto S, Ohota M, Kimura K, Shibano K, Miyake M. Effects of follicle size and electrolytes and glucose in maturation medium on nuclear maturation and developmental competence of bovine oocytes. Reproduction 2004; 127:159-164.
89. Sutton-McDowall ML, Gilchrist RB, Thompson JG. Effect of hexoses and gonadotrophin supplementation on bovine oocyte nuclear maturation during in vitro maturation in a synthetic follicle fluid medium. Reprod Fertil Dev 2005; 17:407-415.
90. Hashimoto S, Minami N, Yamada M, Imai H. Excessive concentration of glucose during in vitro maturation impairs the developmental competence of bovine oocytes after in vitro fertilization: relevance to intracellular reactive oxygen species and glutathione contents. Mol Reprod Dev 2000; 56:520-526.
91. Sutton-McDowall ML, Mitchell M, Cetica P, Dalvit G, Pantaleon M, Lane M, Gilchrist RB, Thompson JG. Glucosamine supplementation during in vitro maturation inhibits subsequent embryo development: possible role of the hexosamine pathway as a regulator of developmental competence. Biol Reprod 2006; 74:881-888.